Company Search:
Advanced Search
Sponsored Links
Swedish Orphan Biovitrum AB (publ) Company Snapshot
Swedish Orphan Biovitrum AB (publ) operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Swedish Orphan Biovitrum AB (publ) with three other pharmaceutical manufacturers in Europe: Recipharm AB (publ) (2015 sales of 3.39 billion Swedish Kronor [US$385.34 million] of which 50% was MS-SO), OTCPharm PAO of Russia (17.85 billion Russian Rubles [US$309.08 million] ), and Vetoquinol Sa which is based in France (342.61 million Euro [US$370.39 million] of which 60% was Operating Segment - Europe).

Sales Analysis. Swedish Orphan Biovitrum AB (publ) reported sales of SEK 3.23 billion (US$366.98 million) for the year ending December of 2015. This represents an increase of 23.8% versus 2014, when the company's sales were SEK 2.61 billion. Sales at Swedish Orphan Biovitrum AB (publ) have increased during each of the previous five years (and since 2010, sales have increased a total of 69%). Sales of Haemophilia:royalties saw an increase that was more than double the company's growth rate: sales were up 211.3% in 2015, from SEK 30.92 million to SEK 96.25 million. Swedish Orphan Biovitrum AB (publ) also saw significant increases in sales in Core Products/kineret (up 32.2% to SEK 805.36 million) and Core Products/orfadin (up 45.2% to SEK 795.71 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Swedish Orphan Biovitrum AB (publ)
  Stock Performance Chart for Swedish Orphan Biovitrum AB (publ)
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 125.50
(Figures in Swedish Kronor)
1 Week 1.3%   13 Weeks 6.5%  
4 Weeks 20.9%   52 Weeks 25.2%  
Swedish Orphan Biovitrum AB (publ) Key Data:
  Ticker: SOBI Country: Sweden
  Exchanges: FRA LON STO OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 3,227,867,000
(Year Ending Jan 2016).
Employees: 672
  Currency: Swedish Kronor Market Cap: 33,728,003,893
  Fiscal Yr Ends: December Shares Outstanding: 268,749,035
  Share Type: Aktie Closely Held Shares: 4,352,175
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.